As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 12/8/20  Diadexus, Inc.                    REVOKED                1:489K                                   SEC #7                   
  8/9/18  Morgan Stanley                    SC 13G/A               1:14K  Diadexus, Inc.                                             
 2/13/18  Morgan Stanley                    SC 13G/A               1:14K  Diadexus, Inc.                                             
 2/13/17  Morgan Stanley                    SC 13G                 1:14K  Diadexus, Inc.                                             
 4/29/16  Diadexus, Inc.                    10-Q        3/31/16   66:5.2M                                   ActiveDisclosure/FA      
 4/29/16‡ Diadexus, Inc.                    8-K:2,9     4/28/16    2:290K                                   ActiveDisclosure/FA      
 4/18/16  Diadexus, Inc.                    8-K:2,9     4/18/16    2:50K                                    ActiveDisclosure/FA      
  4/1/16  Diadexus, Inc.                    8-K:4,9     3/31/16    2:74K                                    ActiveDisclosure/FA      
 3/29/16  Diadexus, Inc.                    10-K       12/31/15   92:12M                                    ActiveDisclosure/FA      
 3/29/16‡ Diadexus, Inc.                    8-K:2,9     3/28/16    2:380K                                   ActiveDisclosure/FA      
 3/28/16‡ Meson Capital Partners LLC        SC 13D      3/25/16    3:368K Diadexus, Inc.                    Olshan Frome Wolosky LLP 
 3/18/16‡ Diadexus, Inc.                    8-K:5       3/14/16    1:25K                                    ActiveDisclosure/FA      
  2/9/16‡ GSK plc                           SC 13G/A               1:33K  Diadexus, Inc.                    Cleary Gottlieb Ste… LLP 
  1/5/16  Diadexus, Inc.                    CT ORDER               1:11K                                    SEC #7                   
10/30/15  Diadexus, Inc.                    10-Q        9/30/15   64:6M                                     ActiveDisclosure/FA      
10/26/15  Diadexus, Inc.                    8-K:2,9    10/26/15    2:384K                                   ActiveDisclosure/FA      
  9/8/15  Diadexus, Inc.                    8-K:1,3      9/4/15    1:16K                                    Donnelley … Solutions/FA 
 8/21/15‡ Diadexus, Inc.                    8-K:7       8/19/15    1:28K                                    ActiveDisclosure/FA      
 8/13/15  Diadexus, Inc.                    10-Q        6/30/15   65:6.4M                                   ActiveDisclosure/FA      
 8/13/15  Diadexus, Inc.                    8-K:2,9     8/13/15    2:400K                                   ActiveDisclosure/FA      

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  /A
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	CT ORDER	SEC Confidential Treatment Order.
	REVOKED	SEC Order Revoking a Registration.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.